PINNACLE ASSOCIATES LTD

Position in GERN — Geron Corp

CIK 743127 NEW YORK, NY

Position in GERN

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$56,687

-$9,567 QoQ

Shares Held

44,287

-0.4% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#152

of 259 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PINNACLE ASSOCIATES LTD holds $169,348,366 across 22 Biotechnology names. GERN ranks #20 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	81,247	$50,660,754
2	IONS	Ionis Pharmaceuticals Inc	419,752	$33,282,136
3	CYTK	Cytokinetics Inc	202,440	$17,245,863
4	ARWR	Arrowhead Pharmaceuticals, Inc.	170,131	$13,867,377
5	STTK	Shattuck Labs, Inc.	1,871,442	$12,987,807
6	VRTX	Vertex Pharmaceuticals Inc / Ma	22,375	$11,114,333
7	INCY	Incyte Corp	68,633	$7,780,236
8	PTCT	Ptc Therapeutics, Inc.	70,435	$5,745,382

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$56,687	44,287	-0.4%	Shares	Sole	2026-08-03
2026-03-31	$66,254	44,466	+0.4%	Shares	Sole	2026-04-22
2025-12-31	$58,458	44,287	0.0%	Shares	Sole	2026-02-05
2025-09-30	$60,673	44,287	-12.3%	Shares	Sole	2025-11-13
2025-06-30	$71,212	50,505	-3.8%	Shares	Sole	2025-08-04
2025-03-31	$83,482	52,505	0.0%	Shares	Sole	2025-05-06
2024-12-31	$185,867	52,505	+4.0%	Shares	Sole	2025-02-14
2024-09-30	$229,292	50,505	0.0%	Shares	Sole	2024-10-25
2024-06-30	$214,141	50,505	0.0%	Shares	Sole	2024-07-30
2024-03-31	$166,666	50,505	0.0%	Shares	Sole	2024-04-26
2023-12-31	$106,565	50,505	0.0%	Shares	Sole	2024-01-19
2023-09-30	$107,070	50,505	0.0%	Shares	Sole	2023-10-24
2023-06-30	$162,121	50,505	—	Shares	Sole	2023-07-27
No filing history on record for this holder in this stock.